Medical Devices Startups
6,515 companies tagged Medical Devices, with their investors and founders.
Arterica is a medical device startup developing a large-bore vascular closure device aimed at improving patient outcomes and lowering healthcare costs. Founded in 2016, it serves cardiologists and vascular surgeons in the cardiovascular device field.
0 investors
Arthroba offers a wearable knee sensor brace using bioimpedance and motion sensors paired with an AI-powered app that measures joint swelling, movement, and strength to generate personalized at-home rehabilitation programs. It targets people with arthritis, knee injuries, and chronic joint pain seeking recovery without drugs, surgery, or clinic visits.
0 investors
Ascendco is a healthcare technology company that helps health systems optimize surgical device purchasing and management through data analytics and software, working compatibly with existing vendor ecosystems.
0 investors
AscentX Medical develops injectable regenerative therapy using autologous tissue engineering with microspheres to restore soft tissue function, targeting the aging population and patients in clinical settings. The company is also launching cGMP aseptic fill and finish contract manufacturing (CMO) services for the pharmaceutical and medical device industries.
0 investors
AseptiScope develops infection prevention technology for healthcare systems, with a flagship product, the DiskCover System, that provides an automated, touch-free barrier to address stethoscope contamination. The company serves clinicians and healthcare systems, with additional infection prevention products in development.
0 investors
ASP (ASP Isotopes) is an advanced materials company developing proprietary technology and processes to produce and enrich isotopes for markets including nuclear medicine and therapeutics, green energy generation, and quantum computing. Its initial focus is constructing plants in South Africa to produce highly enriched isotopes for the nuclear medicine market.
0 investors
Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).
0 investors
AssurTek Surgical develops OsteoSmartSense, an AI-backed system that provides real-time detection of nerves, sinuses, and other vital structures to reduce risks during dental implant surgery. The technology works with any drill and aims to maintain surgical safety boundaries for clinicians performing implant procedures.
0 investors
Augustine Surgical (ASI) develops medical devices focused on patient warming and patient safety technologies for the operating room, including products such as WaffleGrip and Clinician Warming. The company designs and markets these devices for hospitals and surgical settings in the medical device industry.
0 investors
Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
0 investors
RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.
0 investors
Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF). Its Axon Ablation Catheter is used in an outpatient procedure to block nerve signals and normalize volume balance.
0 investors
AyuVis develops novel small-molecule immunotherapies with a unique mode of action to fight inflammation and infection. Founded in 2014, the company focuses on drug discovery and clinical development in areas including neonatal immunology and infectious disease.
0 investors
Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
0 investors
Balance Ophthalmics develops ophthalmic medical technology for treating glaucoma, offering a non-pharmaceutical, non-surgical therapy that lowers intraocular pressure while patients sleep. Its products are intended for eye care professionals and glaucoma patients.
0 investors
Balanced Pharma develops pharmaceutical and medical device products for dental and dermatological applications. The company is led by experienced executives and clinicians with backgrounds in pharmaceutical manufacturing, dentistry, and medical device innovation.
0 investors
BaroPace is developing PressurePace, a closed-loop system that adjusts a cardiac pacemaker in response to real-time blood pressure measurements to treat drug-resistant hypertension and common forms of heart failure. The technology is based on the theory and clinical data of Dr. Michael Burnam linking declining heart rate to hypertensive disease and heart failure.
0 investors
Basis Medical develops the Seclusion catheter and procedure for treating chronic venous insufficiency (CVI), a vein reflux disease affecting the legs. The medical device targets endovenous vein ablation procedures performed at US hospitals and vein centers as an alternative to vein stripping, sclerotherapy, and thermal ablation treatments.
0 investors
BData operates the Burn Care Quality Platform (BCQP), a burn data platform that captures case-level real-world evidence from U.S. burn centers in collaboration with clinicians and the American Burn Association. It provides benchmarking, quality improvement analytics, product utilization data, and custom data sets to support clinical research and FDA regulatory decision-making for burn care and wound covering products.
0 investors
Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
0 investors
NuStat markets an over-the-counter bleeding-control product that the page states meets or exceeds U.S. Department of Defense specifications for quality and functionality. The product is positioned in the medical/hemostatic wound-care category.
0 investors
Belhaven Bio develops a temperature-stable, needle-free delivery device for epinephrine and other emergency medications, designed to be more compact, affordable, and longer-lasting than traditional liquid injectables for patients with severe allergies and anaphylaxis conditions.
0 investors
BellaMia Technologies develops a cart-based laser device for the aesthetics industry, focused on non-invasive skin rejuvenation. The company is in its development phase and its device is not yet available to the market.
0 investors
Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription. The company operates in the medical device and diabetes care space.
0 investors